πŸ‡ΊπŸ‡Έ FDA
Patent

US 8877199

B cell surface reactive antibodies

granted A61KA61K2039/505A61P

Quick answer

US patent 8877199 (B cell surface reactive antibodies) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505, A61P, A61P35/02